Bulletin of the World Health Organization
Print version ISSN 0042-9686
JACKSON, Sukhan; SLEIGH, Adrian C. and LIU, Xi-Li. Cost of malaria control in China: Henan's consolidation programme from community and government perspectives. Bull World Health Organ [online]. 2002, vol.80, n.8, pp. 653-659. ISSN 0042-9686. http://dx.doi.org/10.1590/S0042-96862002000800010.
OBJECTIVE: To assist with strategic planning for the eradication of malaria in Henan Province, China, which reached the consolidation phase of malaria control in 1992, when only 318 malaria cases were reported. METHODS: We conducted a prospective two-year study of the costs for Henan's malaria control programme. We used a cost model that could also be applied to other malaria programmes in mainland China, and analysed the cost of the three components of Henan's malaria programme: suspected malaria case management, vector surveillance, and population blood surveys. Primary cost data were collected from the government, and data on suspected malaria patients were collected in two malaria counties (population 2 093 100). We enlisted the help of 260 village doctors in six townships or former communes (population 247 762), and studied all 12 325 reported cases of suspected malaria in their catchment areas in 1994 and 1995. FINDINGS: The average annual government investment in malaria control was estimated to be US$ 111 516 (case-management 59%; active blood surveys 25%; vector surveillance 12%; and contingencies and special projects 4%). The average cost (direct and indirect) for patients seeking treatment for suspected malaria was US$ 3.48, equivalent to 10 days' income for rural residents. Each suspected malaria case cost the government an average of US$ 0.78. CONCLUSION: Further cuts in government funding will increase future costs when epidemic malaria returns; investment in malaria control should therefore continue at least at current levels of US$ 0.03 per person at risk.
Keywords : Malaria [prevention and control]; Malaria [economics]; Health expenditures; Health care costs; Financing, Government; Costs and cost analysis; Prospective studies; China.